Biological Drugs in Guillain-Barré Syndrome: An Update

BACKGROUND: Guillain-Barré Syndrome (GBS) is currently considered the most common global cause of acute flaccid paralysis. Currently, standard therapy for Guillain-Barré Syndrome includes intravenous immunoglobulin or plasma exchange. Despite medical advances regarding these treatments, many treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Motamed-Gorji, Nazgol, Matin, Nassim, Tabatabaie, Omidreza, Pavone, Piero, Romano, Catia, Falsaperla, Raffaele, Vitaliti, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652014/
https://www.ncbi.nlm.nih.gov/pubmed/27964705
http://dx.doi.org/10.2174/1570159X14666161213114904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652014/
https://www.ncbi.nlm.nih.gov/pubmed/27964705
http://dx.doi.org/10.2174/1570159X14666161213114904

Ejemplares similares